Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
1 other identifier
interventional
28
1 country
2
Brief Summary
The purpose of this study is to examine the efficacy of exercise + therapy to therapy alone to determine if they can improve the effects of prolonged exposure therapy (PE) in reducing symptoms of anxiety associated with Post-traumatic Stress Disorder (PTSD). In addition the two strategies (i.e., exercise + therapy and therapy alone condition) will be compared in terms of levels of brain-derived neurotrophic factor (BDNF). BDNF is a protein that helps to support the survival of existing neurons and stimulate the growth of new neurons and synapses. BDNF is important to learning and memory in general and therefore may be associated with the learning and memory as it relates to PE and corresponding symptoms PTSD improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Sep 2010
Typical duration for phase_3
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 22, 2013
CompletedFirst Posted
Study publicly available on registry
November 28, 2013
CompletedDecember 29, 2015
December 1, 2015
2.8 years
November 22, 2013
December 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PTSD Symptoms
Self-report measure that assesses PTSD symptoms. Will be assessed at each visit throughout the three month protocol.
3 months
Secondary Outcomes (2)
BDNF (by blood sample)
3 months
General Mood and Anxiety Symptoms
3 months
Study Arms (2)
Prolonged Exposure + Exercise
EXPERIMENTALProlonged Exposure Alone
ACTIVE COMPARATORInterventions
75-90 minute weekly psychotherapy sessions x 12 weeks, focused on gradually confronting distressing trauma-related memories and reminders.
30 minutes of moderate-intensity treadmill exercise prior to the Prolonged Exposure
Eligibility Criteria
You may qualify if:
- You have PTSD.
- You are between the ages of 18 and 65.
- You have written physician approval/medical clearance to participate in an exercise protocol.
- You are currently taking no psychotropic medications or are able and willing to discontinue these medications prior to the first PE session.
You may not qualify if:
- You are currently participating in a structured exercise program.
- You have severe depression.
- You have any history of bipolar disorder, psychotic disorder, or obsessive compulsive disorder.
- You have a diagnosis of eating disorder, or substance abuse or dependence (excluding nicotine) within the past six months.
- You have any history of a suicide attempt, or are at a significant risk or self-harm or harm to others.
- You have ever been diagnosed with organic brain syndrome, mental retardation, or other cognitive dysfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
The University of Texas at Austin
Austin, Texas, 78712, United States
Southern Methodist University
Dallas, Texas, 75206, United States
Related Publications (1)
Powers MB, Medina JL, Burns S, Kauffman BY, Monfils M, Asmundson GJ, Diamond A, McIntyre C, Smits JA. Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. Epub 2015 Feb 23.
PMID: 25706090RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate Professor
Study Record Dates
First Submitted
November 22, 2013
First Posted
November 28, 2013
Study Start
September 1, 2010
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
December 29, 2015
Record last verified: 2015-12